Clinical trials are essential to the development of beneficial treatments for NHS patients as the consumers of medicine and healthcare. Clinical trials supported by the pharmaceutical industry play an important part in keeping the NHS at the forefront of modern treatments and research. In addition, commercial research activity offers clinicians early access to the latest technologies for diagnosing and treating disease and is essential for the development of new medicines and healthcare technologies. NHS GG&C supports the conduct of high-quality commercially funded research, carried out to recognised international quality standards, by NHS staff on NHS premises. However, NHS R&I support funding can not be used to support or subsidise industry sponsored R&I and studies should be fully financed to ensure it does not incur a cost to the NHS.